Individual risk assessment for intracranial haemorrhage during thrombolytic therapy-Reference-Cited by-同舟云学术

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

Published:1993-12 Issue:8886-8887 Volume:342 Page:1523-1528
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Simoons ML,de Jaegere P,van Domburg R,Boersma E,Maggioni AP,Franzosi MG,Leimberger JD,Califf R,Schröder R,Knatterud G,Braunwald E

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986

2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988

3. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction;Wilcox;Lancet,1988

4. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction;Simoons;J Am Coll Cardiol,1989

5. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase: twelve month follow up report of the randomized multicentre trial conducted by the Interuniversity Cardiology Institute of the Netherlands;Vermeer;Br Heart J,1988

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic management of ischemic stroke;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-15

2. Acute, periprocedural and longterm antithrombotic therapy in older adults;European Heart Journal;2022-12-07

3. In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)–Acute Coronary Syndrome Project;Age and Ageing;2022-11-01

4. Medical students' confidence and competence with prescribing in ST-elevation myocardial infarction: a mixed-methods study;International Journal of Medical Education;2022-07-29

5. Marine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity;Marine Drugs;2022-01-02